
The primary anti-inflammatory compound in blue-green algae like spirulina is phycocyanin, which has been shown to inhibit the COX-2 enzyme and reduce oxidative stress. While highly effective, it is not typically considered as foundational as Fish Oil or Vitamin D, placing it firmly in the high-impact tier.
- Focuses on
- Most relevant for
- Adults seeking to lower inflammatory blood markers, particularly athletes and those with weight-related inflammatory concerns.
Potential benefits
- Cytokine Management.Meta-analyses and clinical trials indicate that spirulina effectively reduces systemic pro-inflammatory markers, including IL-6, IL-1beta, and TNF-alpha.
- Exercise Inflammation Control.Daily intake may prevent exercise-induced spikes in C-reactive protein (CRP) and accelerate the recovery of inflammatory markers following intense physical activity.
- Targeted Population Support.Evidence suggests reductions in inflammatory markers and improvements in physical quality of life for specific groups, such as individuals with obesity or multiple sclerosis.
Limitations
- Laboratory Marker Focus.Most research demonstrates changes in blood markers rather than confirming long-term relief from inflammatory symptoms or changes in disease progression.
- Spirulina-Specific Evidence.The available studies focus on the Spirulina genus; these findings may not apply to other species of blue-green algae which have different chemical compositions.
- Exercise Interaction.Certain benefits, particularly in obesity-related inflammation, appear significantly more effective when supplementation is combined with high-intensity interval training.
Study evidence
4 studiesResearch on spirulina, a type of Blue-Green Algae, suggests it can reduce some blood markers of inflammation. These findings mainly concern specific health or exercise settings and do not establish symptom relief, disease prevention, or equivalent effects from other blue-green algae products.


